Drugs / Autologous fecal microbiota therapy
Autologous fecal microbiota therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02046525 | Mar 2014 → Dec 2018 | digestive system infectious disorder | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous fecal microbiota therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02046525 ↗ |
| Known as | autoFMT | “autologous fecal microbiota transplantation (autoFMT) may limit gastrointestinal MDRO expansion” PMID 30463925 ↗ Nov 2018 |
| Known as | autologous fecal microbiota transplantation | “autologous fecal microbiota transplantation (autoFMT) may limit gastrointestinal MDRO expansion” PMID 30463925 ↗ Nov 2018 |
| Modality | Other / unclassified | “autologous fecal microbiota transplantation (autoFMT)” PMID 30463925 ↗ Nov 2018 |
| Route | Rectal | “by enema” PMID 30463925 ↗ Nov 2018 |